Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study

This study is a multicenter, prospective, observational study aimed at investigating the efficacy and safety of triple targeted drug therapy in patients with arterial pulmonary hypertension (PAH) who are not at low risk and are receiving initial treatment. The prognosis of arterial pulmonary hypertension is explored.

NCT Number	NCT06753981
Lead Sponsor	Qianfoshan Hospital Collaborators: Chinese Academy of Medical Sciences, Fuwai Hospital, Jianghan University Affiliated Hospital
Conditions	Arterial Pulmonary Hypertension (PAH)
Enrollment	48 participants
Start Date	2024-12-10
Primary Completion	2026-11-14 (estimated)
Study Completion	2027-02-14 (estimated)
Updated on ClinicalTrials.gov	2024-12-31